OVERVIEW

[Diabetes Trends] Novel Pharmacological Approaches to Treating Post-Prandial Hyperglycemia in Type 2 Diabetes is organized by Horizon CME and will be held from Dec 20, 2018 - Dec 20, 2019. This Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credit(s)™.

Overview:
This webcast will review the barriers to treatment intensification and implement strategies to overcome them. The activity will also outline the rationale, safety, and efficacy of fixed-ratio GLP-1 RA + basal insulin agents and discuss strategies for integrating them into treatment regimens for patients with T2DM.

Learning Objectives:
• Recognize the barriers to treatment intensification and implement strategies to overcome them
• Outline the rationale, safety, and efficacy for fixed-ratio GLP-1 RA and basal insulin agents
• Integrate fixed-ratio GLP1 RA and basal insulin agents for the treatment of patients with T2DM

Additional details will be posted as soon as they are available.